Bio-Rad Laboratories Inc.

NYSE: BIO · Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bio-Rad Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-120.1M 64M -715.8M 653.2M -2.17B 383.9M 349.7M 106.3M -1.16B 69M 833.5M -162.8M -925.2M -3.37B -1.57B 3.93B 914.1M 977.4M
Depreciation & Amortization
-38.1M 38.1M 49.3M 38.9M 36.4M 37.1M 37.2M 37.3M 35.8M 35.6M 40M 34.3M 34.1M 33.4M 33.7M 33.7M 33.7M 32.7M
Stock-Based Compensation
-15.3M 15.3M 16.4M 15.6M 15M 15.3M 16.2M 15.9M 12.6M 16.6M 18.1M 15.7M 13.6M 13.5M 15M 13.1M 11.4M 11.7M
Other Working Capital
5.5M -5.5M 58.35M 210.7M -670.5M 69.8M -24M 15.2M -320.3M -17M 224.3M -98.8M -339.8M -1.05B -531.6M 1.07B 196.3M 308.4M
Other Non-Cash Items
333.6M -31.1M 717.3M -764.79M 2.89B -420.51M -313.85M -59.29M 1.59B 17.22M -949.88M 296.23M 1.34B 4.55B 2.16B -4.87B -1.03B -1.18B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-43.6M 43.6M 56.95M 220.7M -679.5M 54M -8.2M -2.5M -381.8M -40.3M 148.7M -172.4M -409.8M -1.17B -475.8M 1.12B 226.7M 271M
Operating Cash Flow
116.5M 129.9M 124.15M 163.61M 97.65M 69.79M 81.05M 97.71M 98.07M 98.12M 90.42M 11.03M 53.27M 50.49M 157.92M 230.36M 154.62M 113.61M
Capital Expenditures
-45.7M -34.4M -42.9M -63.64M -42.28M -40.18M -42.24M -44.07M -34.64M -35.73M -46.93M -27.57M -17.33M -33.08M -43.24M -34.63M -23.39M -19.55M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 2.5M n/a n/a n/a n/a -100.75M n/a n/a -125.52M n/a n/a n/a
Purchase of Investments
-153.2M -153.4M -222.94M -399.12M -248.08M -406.46M -151.5M -196.02M -137.93M -203.59M -253.09M -328.72M -517.49M -960.94M -845.01M -204.78M -180.35M -74.92M
Sales Maturities Of Investments
300.1M 190.7M 235.35M 407.06M 259.37M 403.51M 263.34M 230.52M 200.52M 168.84M 230.66M 368.61M 388.88M 77.88M 459.28M 158.02M 103.46M 46.13M
Other Investing Acitivies
-216.6M n/a -39K -23.35M 66K 26K 107K 65K 39K n/a -1.33M 6K 1.47M n/a n/a 39K 1K 12K
Investing Cash Flow
-115.4M 2.9M -30.54M -55.64M -30.93M -43.09M 72.2M -9.5M 27.98M -70.47M -69.31M -88.42M -144.48M -916.14M -554.48M -81.35M -100.28M -48.33M
Debt Repayment
-200K -100K -41K -123K -118K -118K -118K -118K -116K -115K -143K -113K -150K 1.19B -1.38M -122K -122K -1.4M
Common Stock Repurchased
-140.2M -101.9M -14K -97.84M -101M -4.75M -200M -21.32M -207.41M n/a -90.68M n/a -125M n/a n/a n/a n/a -50M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-100K 4.3M -26.19M 1.97M 4.53M 4.89M -502K -5.16M 4.79M 4.42M 4.2M -8.66M 3.82M 4.18M 6.01M -15.46M 2.99M 4.05M
Financial Cash Flow
-136.3M -97.7M -26.25M -95.99M -96.59M 21K -200.62M -26.6M -202.74M 4.31M -86.62M -8.77M -121.33M 1.19B 4.63M -15.58M 2.87M -47.35M
Net Cash Flow
-151.4M 33.3M 77.61M 4.47M -26.04M 29.38M -53.95M 67.83M -74.02M 29.96M -83.7M -78.66M -205.75M 331.52M -393.39M 127.36M 59.46M 10.59M
Free Cash Flow
70.8M 95.5M 81.25M 99.97M 55.37M 29.62M 38.8M 53.64M 63.43M 62.39M 43.49M -16.55M 35.94M 17.42M 114.68M 195.74M 131.24M 94.06M